Keyword: GlaxoSmithKline (GSK)

News

Search to Replace GSK Chief Said Underway

01.03.2016 - British drugmaker GlaxoSmithKline is said to have launched a search for a new CEO to replace Andrew Witty, who is now widely expected to step down at the latest by the end of 2017...

News

GSK Fined for Blocking Copies of Seroxat

15.02.2016 - Major UK drugs firm GlaxoSmithKline (GSK) has been fined more than £37 million by the Competition and Markets Authority (CMA) for anti-competitive behavior relating to generic...

News

GSK Chief Says UK “Better in EU”

05.02.2016 - Glaxo SmithKline CEO Andrew Witty has become the first pharmaceutical or chemical company executive to come out in favor of the UK remaining in the EU, although business leaders in...

News

J&J and GSK Join Medicxi Ventures

05.02.2016 - Major drugs companies Johnson & Johnson (J&J) and GlaxoSmithKline (GSK) have become partners in a €210 million life sciences venture capital fund. Both groups will each contribute...

News

Industry and Universities Combine to Create Apollo Therapeutics Fund

28.01.2016 - Three major drugs companies have joined forces with three leading UK universities to translate ground-breaking academic science into new medicines for a broad range of diseases...

News

GAVI and US Merck Link on Ebola Vaccine

27.01.2016 - Geneva, Switzerland-based GAVI (Global Alliance for Vaccines and Immunization), a public-private partnership, and Merck Sharp & Dohme (MSD), known in the US as Merck & Co, have...

News

Drug Firms Urge Governments to Fight Superbugs

26.01.2016 - More than 80 international drug and biotechnology companies have urged governments to work with them to combat the emergence of drug-resistant superbugs, according to a report by...

News

New Immunotherapy Coalition Launched in US

13.01.2016 - Five major internationally active drugmakers, including American biotech firms Amgen and Celgene, along with pharmaceutical giant Pfizer and non-US players such as Glaxo SmithKline...